Rheumatology Doctors in Morristown, NJ Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Mr. Barry J Efros, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 95 Madison Ave, Suite A04, Morristown, NJ 07960 Phone: 973-540-8744    Fax: 973-540-1614

Dr. Janet Beth Bartov, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 435 South St, Suite 220 B, Morristown, NJ 07960 Phone: 973-540-9198    Fax: 973-540-1614

Marla Hochfeld, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 7 Egbert Hill Rd, Morristown, NJ 07960 Phone: 908-347-1083

Mark Adam Tratenberg, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 435 South St, Suite 220b, Morristown, NJ 07960 Phone: 973-540-9198    Fax: 973-540-1614

Dr. David Widman, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 435 South St, Suite 220b, Morristown, NJ 07960 Phone: 973-540-9198    Fax: 973-540-1614

News Archive

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $31.6 million debt financing expansion with Proteus Digital Health. The financing package, which was provided to Proteus Digital Health from both Oxford and Silicon Valley Bank, included a senior secured term loan and a revolving line of credit. Proceeds of the loan will be used for working capital growth.

80% of cancer patients use some form of complementary or alternative therapies

Plug the terms "alternative" and "cancer" into Google and the Internet search engine returns a list of 3.27 million - yes, million - sites with information both credible and questionable about nontraditional treatments for cancer. What's a cancer patient to make of such a vast array of options?

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.

Future diabetes drugs may target new protein interaction

In the March 3 issue of Nature, Johns Hopkins researchers report that two proteins best known for very different activities actually come together to turn the liver into a sugar-producing factory when food is scarce.

AHR plays role in modulating the body's innate immune response to viral infections

A receptor, first known for its role in mediating the harmful effects of the environmental pollutant dioxin in our body, is now understood to play other important roles in modulating the innate immune response.

Read more Medical News

› Verified 4 days ago